SPARN has developed a number of guidelines, protocols and pathways to support clinicians with the care of a patient with a rheumatological condition. Additional guidelines are being developed in 2023/24. Please check back soon for updates.
SPARN Guidelines | Review date |
---|---|
Methylprednisolone | 11/2024 |
Varicella (chickenpox) | 04/2024 |
‘COVID digits’ | 03/2025 |
Initial Diagnosis of Macrophage Activation Syndrome | 03/2025 |
Flu statement | 07/2024 |
Varicella Exposure | |
Pamidronate Protocol | |
Rituximab Guideline | |
Iloprost Guideline | |
CNO Guideline | |
Infliximab Guideline | |
NSAIDs Guideline |
_________________
External Guidelines |
---|
BSR – Guidance Management Symptomatic Hypermobility |
WHO – Guidance for the Management of Chronic Pain in Children |
NICE – Vitamin D deficiency in children Guideline |
_________________
Pathways & Resources | Review date |
---|---|
Pamidronate Protocol | 05/2024 |
Checklist for clinical guideline development | 04/2024 |
SPARN Standard for Paediatric Rheumatology Clinics | 03/2025 |
Raynaud’s Advice sheet | 04/2024 |
Raynaud’s holiday advice | 03/2023 |
Clinic Proforma | 30/2022 |
Joint Injection Request Proforma | |
Referral Pathway for Children with Joint Hypermobility | |
Standards of care for children and young people with JIA |